158 related articles for article (PubMed ID: 37249700)
1. Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients.
Ottenhausen M; Conrad J; Wolters LM; Ringel F
Neurosurg Rev; 2023 May; 46(1):128. PubMed ID: 37249700
[TBL] [Abstract][Full Text] [Related]
2. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience.
Marić A; Kruljac I; Čerina V; Pećina HI; Šulentić P; Vrkljan M
Croat Med J; 2012 Jun; 53(3):224-33. PubMed ID: 22661135
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Endoscopic Transsphenoidal Resection for Prolactinoma: A Retrospective Multicenter Case-series.
Zandbergen IM; Huntoon KM; White TG; Bakker LEH; Verstegen MJT; Ghalib LM; van Furth WR; Pelsma ICM; Dehdashti AR; Biermasz NR; Prevedello DM
Arch Med Res; 2023 Dec; 54(8):102919. PubMed ID: 38040527
[TBL] [Abstract][Full Text] [Related]
4. Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.
Locatelli D; Veiceschi P; Castelnuovo P; Tanriover N; Evliyaoglu O; Canaz H; Ugurlar D; Gazioglu N
Childs Nerv Syst; 2019 Nov; 35(11):2119-2126. PubMed ID: 31079182
[TBL] [Abstract][Full Text] [Related]
5. Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists.
Park K; Park KH; Park HR; Lee JM; Kim YH; Kim DY; Won TB; Kong SH; Kim JH; Shin CS; Paek SH
J Korean Med Sci; 2021 Apr; 36(15):e97. PubMed ID: 33876586
[TBL] [Abstract][Full Text] [Related]
6. Transnasal surgery for prolactin-secreting pituitary adenomas in childhood and adolescence.
Abe T; Lüdecke DK
Surg Neurol; 2002 Jun; 57(6):369-78; discussion 378-9. PubMed ID: 12176193
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgery.
Yi N; Ji L; Zhang Q; Zhang S; Liu X; Shou X; Lu B
Endocrine; 2018 Oct; 62(1):76-82. PubMed ID: 29934876
[TBL] [Abstract][Full Text] [Related]
8. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients.
Kreutzer J; Buslei R; Wallaschofski H; Hofmann B; Nimsky C; Fahlbusch R; Buchfelder M
Eur J Endocrinol; 2008 Jan; 158(1):11-8. PubMed ID: 18166812
[TBL] [Abstract][Full Text] [Related]
9. Microscopic endonasal transsphenoidal pituitary adenomectomy in the pediatric population.
Tarapore PE; Sughrue ME; Blevins L; Auguste KI; Gupta N; Kunwar S
J Neurosurg Pediatr; 2011 May; 7(5):501-9. PubMed ID: 21529190
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
11. SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP.
Donegan D; Atkinson JL; Jentoft M; Natt N; Nippoldt TB; Erickson B; Meyer F; Erickson D
Endocr Pract; 2017 Jan; 23(1):37-45. PubMed ID: 27682355
[TBL] [Abstract][Full Text] [Related]
12. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic Transsphenoidal Surgery of Microprolactinomas: A Reappraisal of Cure Rate Based on Radiological Criteria.
Micko A; Vila G; Höftberger R; Knosp E; Wolfsberger S
Neurosurgery; 2019 Oct; 85(4):508-515. PubMed ID: 30169711
[TBL] [Abstract][Full Text] [Related]
15. The Combination of Dopamine Agonist Treatment and Surgery May Be the Best Option in Challenging Prolactinoma Cases: A Single-Centre Experience.
Demir D; Demir AN; Sulu C; Zulfaliyeva G; Cetintas SC; Ozkaya HM; Kadioglu P; Gazioglu N; Tanriover N
World Neurosurg; 2023 Jul; 175():e1166-e1174. PubMed ID: 37120141
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
[TBL] [Abstract][Full Text] [Related]
17. Transsphenoidal surgery for a life-threatening prolactinoma apoplexy during pregnancy.
Witek P; Zieliński G; Maksymowicz M; Zgliczyński W
Neuro Endocrinol Lett; 2012; 33(5):483-8. PubMed ID: 23090264
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature.
Rahimli T; Hidayetov T; Yusifli Z; Memmedzade H; Rajabov T; Aghayev K
World Neurosurg; 2021 May; 149():e1043-e1055. PubMed ID: 33524611
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
20. Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience.
Lasolle H; Teulade M; Lapras V; Vasiljevic A; Borson-Chazot F; Jouanneau E; Raverot G
Ann Endocrinol (Paris); 2022 Feb; 83(1):1-8. PubMed ID: 34871604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]